Of 5 the Hon. Karen Andrews, MP 25 October 2018 Minister for Industry

Total Page:16

File Type:pdf, Size:1020Kb

Of 5 the Hon. Karen Andrews, MP 25 October 2018 Minister for Industry The Hon. Karen Andrews, MP 25 October 2018 Minister for Industry, Science and Technology Parliament House, Canberra [email protected] cc: The Hon. Stuart Robert MP, cc: Senator Kim Carr Dear Minister, Complementary Medicines Australia (CMA) writes to you to confirm that the sentiments raised at Senate Estimates today are what members of the complementary medicines industry have been asserting, that the current application of the ACCC Country of Origin Guidelines for complementary healthcare products will have significant detrimental impacts on the industry’s $1.2 billion export market and threaten a 30,000 strong work force that supports a 4.9 billion dollar industry. The revised Country of Origin guidance, released in March this year, means that by extension over 200 licensees to the Australian Made logo are currently in danger of having their ‘Made in Australia’ credentials revoked and the hurdles increased. If complementary medicines that are manufactured and tested in Australia cannot claim “Made in Australia”, the result will cause unnecessary yet serious impact on the industry and wider global reputation including reduction in investment into Australia, job losses and hinder industry growth. We urge you to prevent one of the few remaining growth manufacturing industries in Australia from being jeopardised. It is counter-productive to the competitive advantage enjoyed by manufacturing complementary medicines in Australia as a result of maintaining the high quality pharmaceutical standards expected here. Instead it would force businesses to consider following the path of many pharmaceutical companies in needing to exit Australia and move off-shore. The higher input costs of labour, electricity and regulatory compliance means our industry does not and cannot compete globally on price. Competitive advantage is based on our high-quality testing and manufacturing standards. Australian consumers need to know that the vitamins they consume have been manufactured in Australia under the most rigorous regulatory framework in the world. Forcing the Australian manufacturing industry off-shore is not in the interests of Australian consumers, or the thousands of workers employed in the industry. It is well known that many consumers, especially those in the Asia-Pacific region, look for the ‘Made in Australia’ claim or the ‘Made in Australia’ logo as proof of authenticity and the high quality, trusted, standards synonymous with complementary medicines made in Australia. CMA, on behalf of industry, will continue to work with the Government to ensure support for manufacturers and a level of certainty for businesses, in the consistent application of Country of Origin and Australian Made provisions. To this extent, it is proposed that an urgent amendment be made to the Competition and Consumer Regulations 2010, that would acknowledge all finished medicinal Beyond Bank Building, Level 1 P +61 2 6260 4022 ACN 169 036 088 PO Box 450 www.cmaustralia.org.au 105 Mawson Drive Mawson ACT 2607 Mawson ACT 2607 [email protected] F +61 2 6260 4122 Page 1 of 5 products manufactured in Australia, under Good Manufacturing Practice (GMP), as meeting the criteria for substantial transformation in this country. Yours sincerely, Mr Carl Gibson Chief Executive Officer Complementary Medicines Australia Agreed to and co-signed by the Australian Complementary Medicines Industry Dusko Pejnovic Stephen Walker, General Manager CEO, Lipa Pharmaceuticals Sanofi Consumer Healthcare Russell Scott CEO, Ferngrove Pharmaceuticals Australia Pty Ltd Dr Aniss Chami, CEO Vitex Pharmaceuticals Russell Parker CEO – Melrose and Orchard Richard Henfrey, CEO, Blackmores Beyond Bank Building, Level 1 P +61 2 6260 4022 ACN 169 036 088 PO Box 450 www.cmaustralia.org.au 105 Mawson Drive Mawson ACT 2607 Mawson ACT 2607 [email protected] F +61 2 6260 4122 Page 2 of 5 Jeffrey Yeh, Operations Director Homart Pharmaceuticals Executive Chairman & Founder Caruso's Natural Health Michelle Aitkin, Head Regulatory Justin Howden, Group Head Evolution health Global Government Affairs and Industry Development Swisse Wellness Howard Biggs, General Manager Personalcare at PharmaCare Laboratories Beyond Bank Building, Level 1 P +61 2 6260 4022 ACN 169 036 088 PO Box 450 www.cmaustralia.org.au 105 Mawson Drive Mawson ACT 2607 Mawson ACT 2607 [email protected] F +61 2 6260 4122 Page 3 of 5 Rational for proposed change to the Competition and Consumer Regulations 2010 The Competition and Consumer Act 2010 , subsection 255(3)(b), provides a mechanism for including in the Regulations examples of particular classes of goods that have undergone certain process that would otherwise have the same result as those described in subsection 2(b), the ‘substantially transformed’ definition. Subsection 255(3)(b) of the Act provides that: ‘Without limiting subsection (2), the [Competition and Consumer] regulations may include examples (in relation to particular classes of goods or otherwise) of processes or combinations of processes that, for the purposes of that subsection, have the result described in subsection (2)(b).’ Therefore, it is proposed that wording to the following effect be included in the Regulations for the purposes of 255(3)(b): “In relation to the class of goods that are finished medicinal products, the combination of processes specified for this part are the ‘manufacture of dosage form’ and ‘packaging and labelling’, when performed in accordance with prescribed Manufacturing Principles within the Therapeutic Goods Act.” This mechanism would efficiently and succinctly address the unintended consequences that have arisen due to the amended Australian Consumer Law. That is; the production of medicines, which when manufactured under processes of Good Manufacturing Practice, substantially transforms them into goods that are fundamentally different in identity, nature, or essential character from the raw material components used in their production. By doing so, the legislative application and reasonable consumer test remains as to whether “as a result of one or more processes undertaken in that country, the goods are fundamentally different in identity, nature or essential character from all of their ingredients or components that were imported into that country.” Explanatory note: 1. Therapeutic goods, by Australian law, include goods that are represented in any way to be, or that are because of the way in which the goods are presented, likely to be taken for therapeutic use. 2. Finished medicinal products (also referred to ‘finished products*’) are a class of therapeutic goods that are represented to be and presented in a way that they are likely to be taken for therapeutic use by consumers. They are fundamentally different in identity, nature, or essential character from all of their imported ingredients or components – none of which are goods that are represented to be, or are presented as goods that have the identity, nature, or essential character goods that are designed to be taken for therapeutic use. 3. Whilst the majority of ingredients (chemical or biological) cannot be consumed at all in their imported raw material form, even an ingredient that could be consumed, such as fish oil, could not meet the identity of Beyond Bank Building, Level 1 P +61 2 6260 4022 ACN 169 036 088 PO Box 450 www.cmaustralia.org.au 105 Mawson Drive Mawson ACT 2607 Mawson ACT 2607 [email protected] F +61 2 6260 4122 Page 4 of 5 being a finished medicinal product, because raw fish oil in it’s existing form, is by Australian legislative definition a food product, which is not represented to be or presented in a way that it is likely to be taken for therapeutic use, nor is it required to be processed under prescribed Manufacturing Principles for therapeutic goods. 4. The class of goods known as finished medicinal products are goods that are fundamentally different in nature, identity, and essential character from all of its individual ingredients (active ingredients or excipients) and all of its other necessary components (packaging and labelling components). 5. In order for goods to be represented to be, and presented for supply as, finished medicinal products, a combination of two manufacturing processes must occur, both of which are required TGA steps of medicine manufacture: 1. “Manufacture of dosage form” This step involves a series of complex manufacturing processes that is necessary to present a finished medicinal product in its final pharmaceutical form intended for therapeutic use and are therefore processes that are essential in the transformation in the nature, identity and essential character of the goods. 2. “Packaging and labelling”. By representing the therapeutic purpose of the goods, this step forms part of the necessary transformation of the identification of goods into finished medicinal products. 6. Both of these steps are processes which are required to be performed under specified Manufacturing Principles for the Therapeutic Goods Act 1989. *https://www.tga.gov.au/acronyms-glossary#summary-f Competition and Consumer Act 2010 (2) Goods were substantially transformed in a country if: (a) the goods met, in relation to that country, the requirements of item 1 or 2 in the second column of the table in subsection (1); or (b) as a result of one or more processes undertaken in that country, the goods are fundamentally different in identity, nature or essential character from all of their ingredients or components that were imported into that country. (3) Without limiting subsection (2), the regulations: (a) may prescribe (in relation to particular classes of goods or otherwise) processes or combinations of processes that, for the purposes of that subsection, do not have the result described in subsection (2)(b); and (b) may include examples (in relation to particular classes of goods or otherwise) of processes or combinations of processes that, for the purposes of that subsection, have the result described in subsection (2)(b). Beyond Bank Building, Level 1 P +61 2 6260 4022 ACN 169 036 088 PO Box 450 www.cmaustralia.org.au 105 Mawson Drive Mawson ACT 2607 Mawson ACT 2607 [email protected] F +61 2 6260 4122 Page 5 of 5 .
Recommended publications
  • Liberal Women: a Proud History
    <insert section here> | 1 foreword The Liberal Party of Australia is the party of opportunity and choice for all Australians. From its inception in 1944, the Liberal Party has had a proud LIBERAL history of advancing opportunities for Australian women. It has done so from a strong philosophical tradition of respect for competence and WOMEN contribution, regardless of gender, religion or ethnicity. A PROUD HISTORY OF FIRSTS While other political parties have represented specific interests within the Australian community such as the trade union or environmental movements, the Liberal Party has always proudly demonstrated a broad and inclusive membership that has better understood the aspirations of contents all Australians and not least Australian women. The Liberal Party also has a long history of pre-selecting and Foreword by the Hon Kelly O’Dwyer MP ... 3 supporting women to serve in Parliament. Dame Enid Lyons, the first female member of the House of Representatives, a member of the Liberal Women: A Proud History ... 4 United Australia Party and then the Liberal Party, served Australia with exceptional competence during the Menzies years. She demonstrated The Early Liberal Movement ... 6 the passion, capability and drive that are characteristic of the strong The Liberal Party of Australia: Beginnings to 1996 ... 8 Liberal women who have helped shape our nation. Key Policy Achievements ... 10 As one of the many female Liberal parliamentarians, and one of the A Proud History of Firsts ... 11 thousands of female Liberal Party members across Australia, I am truly proud of our party’s history. I am proud to be a member of a party with a The Howard Years ..
    [Show full text]
  • Dirty Power: Burnt Country 1 Greenpeace Australia Pacific Greenpeace Australia Pacific
    How the fossil fuel industry, News Corp, and the Federal Government hijacked the Black Summer bushfires to prevent action on climate change Dirty Power: Burnt Country 1 Greenpeace Australia Pacific Greenpeace Australia Pacific Lead author Louis Brailsford Contributing authors Nikola Čašule Zachary Boren Tynan Hewes Edoardo Riario Sforza Design Olivia Louella Authorised by Kate Smolski, Greenpeace Australia Pacific, Sydney May 2020 www.greenpeace.org.au TABLE OF CONTENTS Executive summary 4 1. Introduction 6 2. The Black Summer bushfires 7 3. Deny, minimise, adapt: The response of the Morrison Government 9 Denial 9 Minimisation 10 Adaptation and resilience 11 4. Why disinformation benefits the fossil fuel industry 12 Business as usual 13 Protecting the coal industry 14 5. The influence of the fossil fuel lobby on government 16 6. Political donations and financial influence 19 7. News Corp’s disinformation campaign 21 News Corp and climate denialism 21 News Corp, the Federal Government and the fossil fuel industry 27 8. #ArsonEmergency: social media disinformation and the role of News Corp and the Federal Government 29 The facts 29 #ArsonEmergency 30 Explaining the persistence of #ArsonEmergency 33 Timeline: #ArsonEmergency, News Corp and the Federal Government 36 9. Case study – “He’s been brainwashed”: Attacking the experts 39 10. Case study – Matt Kean, the Liberal party minister who stepped out of line 41 11. Conclusions 44 End Notes 45 References 51 Dirty Power: Burnt Country 3 Greenpeace Australia Pacific EXECUTIVE SUMMARY stronger action to phase out fossil fuels, was aided by Rupert Murdoch’s News Corp media empire, and a Australia’s 2019/20 Black coordinated campaign of social media disinformation.
    [Show full text]
  • Second Morrison Government Ministry 29 June 2021 Overview
    Barton Deakin Brief: Second Morrison Government Ministry 29 June 2021 Overview Prime Minister Scott Morrison MP has announced his new Cabinet and Ministry following the change in The Nationals leadership. Cabinet Changes - Barnaby Joyce MP is the new Deputy Prime Minister and Minister for Infrastructure, Transport and Regional Development. Michael McCormack MP has been removed from the Cabinet and is now on the backbench. - David Littleproud MP retains his position as the Minster for Agriculture and is now also the Minister for Northern Australia. The role of Minister for Drought and Emergency Management will be given to Senator Bridget McKenzie. - Senator McKenzie will be returned to the Cabinet and is also the new Minister for Regionalisation, Regional Communications and Regional Education. - Keith Pitt MP, the Minister for Resources and Water will move to the outer Ministry, with his Northern Australia portfolio goes to David Littleproud MP. - Andrew Gee MP has been promoted to the Cabinet as the Minister for Defence Industry and Minister for Veterans’ Affairs. - Darren Chester MP, the former Minister for Veterans Affairs and Defence Personnel has been removed from the Cabinet and the Ministry. Ministry Changes - Mark Coulton MP, formerly the Minister for Regional Health, Regional Communications and Local Government is no longer a Minister. - Dr David Gillespie MP has become the Minister for Regional Health. For more information - The Ministry List from the Department of Prime Minister and Cabinet For more information, contact David Alexander on +61 457 400 524, Grahame Morris on +61 411 222 680, Cheryl Cartwright on +61 419 996 066 or Jack de Hennin on +61 424 828 127.
    [Show full text]
  • Rapid Research Information Forum, the Predictive Value Of
    30 April 2020 The Hon Greg Hunt MP Minister for Health Parliament House CANBERRA ACT 2600 CC: The Hon Karen Andrews MP, Minister for Industry, Science and Technology Dr Brendan Murphy, Chief Medical Officer Dear Minister Please find attached a response to your request for advice on the predictive value of serological antibody tests and the comparability of point-of-care tests to laboratory tests. This rapid response has been prepared by the Rapid Research Information Forum that I Chair. The report synthesises the evidence base on this matter and has been informed by relevant experts and has been peer reviewed. Details of the authors and peer reviewers can be found in the Appendix. I hope this document proves useful to you and your colleagues. Yours sincerely, Dr Alan Finkel AO FAA FTSE FAHMS Australia’s Chief Scientist GPO Box 2013 Telephone: +61 2 6102 9210 Email: [email protected] Canberra ACT 2601 Facsimile: +61 2 6213 6558 Web: www.chiefscientist.gov.au Australia Rapid Research Information Forum The predictive value of serological testing during the COVID-19 pandemic 30 April 2020 This rapid research brief responds to the request for advice on the predictive value of serological antibody tests and the comparability of point-of-care (POC) tests to laboratory tests. • Point-of-care (POC) and laboratory-based serological tests can be used to detect antibodies against SARS-CoV-2. Globally, health authorities are evaluating their use to determine individual immunity, the prevalence of infection in the population, to aid in diagnosis, to aid in contact tracing, and to inform when restrictions can be eased.
    [Show full text]
  • Commonwealth of Australia
    Commonwealth of Australia Author Wanna, John Published 2019 Journal Title Australian Journal of Politics and History Version Accepted Manuscript (AM) DOI https://doi.org/10.1111/ajph.12576 Copyright Statement © 2019 School of History, Philosophy, Religion and Classics, School of Political Science and International Studies, University of Queensland and Wiley Publishing Asia Pty Ltd. This is the peer reviewed version of the following article: Commonwealth of Australia, Australian Journal of Politics and History, Volume 65, Issue 2, Pages 295-300, which has been published in final form at 10.1111/ajph.12576. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving Downloaded from http://hdl.handle.net/10072/388250 Griffith Research Online https://research-repository.griffith.edu.au Commonwealth of Australia John Wanna Turnbull’s Bizarre Departure, and a Return to Minority Government for the Morrison-led Coalition Just when political pundits thought federal parliament could not become even wackier than it had been in recent times, the inhabitants of Capital Hill continued to prove everyone wrong. Even serious journalists began referring to the national legislature metaphorically as the “monkey house” to encapsulate the farcical behaviour they were obliged to report. With Tony Abbott being pre-emptively ousted from the prime ministership by Malcolm Turnbull in 2015, Turnbull himself was, in turn, unceremoniously usurped in bizarre circumstances in August 2018, handing over the leadership to his slightly bemused Treasurer Scott Morrison. Suddenly, Australia was being branded as the notorious “coup capital of the Western democracies”, with five prime ministers in five years and only one losing the high office at a general election.
    [Show full text]
  • Social Media Thought Leaders Updated for the 45Th Parliament 31 August 2016 This Barton Deakin Brief Lists
    Barton Deakin Brief: Social Media Thought Leaders Updated for the 45th Parliament 31 August 2016 This Barton Deakin Brief lists individuals and institutions on Twitter relevant to policy and political developments in the federal government domain. These institutions and individuals either break policy-political news or contribute in some form to “the conversation” at national level. Being on this list does not, of course, imply endorsement from Barton Deakin. This Brief is organised by categories that correspond generally to portfolio areas, followed by categories such as media, industry groups and political/policy commentators. This is a “living” document, and will be amended online to ensure ongoing relevance. We recognise that we will have missed relevant entities, so suggestions for inclusions are welcome, and will be assessed for suitability. How to use: If you are a Twitter user, you can either click on the link to take you to the author’s Twitter page (where you can choose to Follow), or if you would like to follow multiple people in a category you can click on the category “List”, and then click “Subscribe” to import that list as a whole. If you are not a Twitter user, you can still observe an author’s Tweets by simply clicking the link on this page. To jump a particular List, click the link in the Table of Contents. Barton Deakin Pty. Ltd. Suite 17, Level 2, 16 National Cct, Barton, ACT, 2600. T: +61 2 6108 4535 www.bartondeakin.com ACN 140 067 287. An STW Group Company. SYDNEY/MELBOURNE/CANBERRA/BRISBANE/PERTH/WELLINGTON/HOBART/DARWIN
    [Show full text]
  • ATSE Annual Review 2018-2019
    Annual Review 2018—2019 Our 2017-2020 Strategy Plan covers of electing 40 per cent of new Fellows We launched Shifting gears — Preparing eight important areas. Since strategy from industry and government will for a Transport Revolution in April is ultimately about directional change, need more focus in future years. 2019 at a Melbourne event hosted here I want to focus on three of our by the Committee for the Economic top priorities that are different from Membership isn’t the only area where Development of Australia. “business as usual”: we’re achieving results in diversity. The Science in Australia Gender The report generated substantial 1. amplifying impact Equity (SAGE) program, a partnership media and social media coverage and 2. diversity and inclusion between ATSE and the Academy of subsequent opportunities to present its 3. preparing Australia for a future of Science, awarded the first Athena recommendations to government and disruptive technological change. Swan Bronze Awards to a cohort of to transport-related conferences. Work Professor Hugh Bradlow FTSE institutions. And the Women in STEM has begun on the second report which The most contentious of these, Decadal Plan, another collaboration will examine the readiness of the health President amplifying impact, is still a work in with the Academy of Science, is services to adopt new technologies. progress. The brand refresh generated encouraging diversity and inclusion a lot of debate, and has since been across STEM sectors. I would like to thank the many finessed to encompass a range of Fellows who have made invaluable Fellows views. ATSE’s brand now We’re also proud of our Industry contributions this year — whether balances our rich, ongoing history Mentoring Network in STEM (IMNIS) as Board members, members of with a bold visual identity and a initiative, which breaks down barriers Assembly or Division committees, 21st century web presence.
    [Show full text]
  • The Hon Karen Andrews MP the Hon Keith Pitt MP
    The Hon Karen Andrews MP Minister for Industry, Science and Technology The Hon Keith Pitt MP Minister for Resources, Water and Northern Australia JOINT MEDIA RELEASE NT CRITICAL MINERALS PROJECTS CHARGING AHEAD 13 March 2021 The Morrison Government continues to strengthen the nation’s critical minerals sector, with support for two large job creating projects in the Northern Territory. Major Project Status has been granted to the Finniss Lithium Mine Project and the Mount Peake Vanadium, Titanium and Iron Mine and Processing Facility. The Mount Peake project will see a mine site established about 235kms north of Alice Springs and a facility set up in Darwin to produce and process vanadium, titanium and iron. This will create up to 1,600 jobs during construction and up to 1000 ongoing jobs during operation. The Finniss Project will develop a mining facility near Darwin Port, which will produce highly sought after lithium and generate more than 360 jobs during construction and more than 250 ongoing jobs during operation. Minister for Industry, Science and Technology Karen Andrews said the projects will bring huge economic benefits to the Northern Territory and the rest of Australia. “Lithium is a valuable export which will only become more important in the future, thanks to its use in a range of everyday items from electric car batteries to smart phones, pace makers and digital cameras,” Minister Andrews said. “Products using vanadium, titanium and iron are also in great demand and these two projects will see our nation capturing more value from these resources, which will create jobs in the Northern Territory and economic opportunities for all of Australia.
    [Show full text]
  • October-December 2016 Achievements October-December 2016
    Activities & October-December 2016 Achievements October-December 2016 Highlights CEO: James Pearson This quarter the Australian Chamber hosted several major events to connect our members with leading figures in business, politics, government and media. The Prime Minister Malcolm Turnbull addressed the Australian Prime Minister the Hon Malcolm Turnbull MP addresses guests at the Chamber Business Leaders Dinner in November. The gala Business Leaders Dinner. event, sponsored by MYOB, CareSuper, the Australian Made Campaign and 3 Degrees Marketing, attracted more than 360 members heard briefings from Treasury Secretary John Fraser on members and guests at the National Gallery of Australia. the state of the economy and former Foreign Minister Bob Carr on the implications of Donald Trump’s election. The Australian Chamber Business Leaders Summit in October hosted leaders from across the chamber network in Canberra We welcomed Campbell Page, Laureate Australia, National Heart to discuss issues including workplace relations, infrastructure, Foundation, Pfizer, Sanofi and Telstra as newBusiness Leaders tourism and vocational education. The event, sponsored by Google Council members, bringing the total to 45. Australia and Fairfax Media, concluded with a cocktail reception at Parliament House attended by dozens of members of Parliament. We welcomed to the team Paul Cristofani (Director of Work Health and Safety and Workers’ Compensation Policy), Scott At our Annual General Meeting in November, President Terry Barklamb (Director of Workplace Relations
    [Show full text]
  • Barton Deakin Brief: New Morrison Government Ministry 29 March 2021
    Barton Deakin Brief: New Morrison Government Ministry 29 March 2021 Overview Prime Minister Scott Morrison MP has announced his new Cabinet and Ministry and his new Cabinet Taskforce for Women. The changes include the creation of three new portfolio roles in respect to women’s issues. Cabinet Changes - Senator Michaelia Cash will take over the role of Attorney-General and Minister for Industrial Relations. The role of Minister for Employment, Workforce, Skills, Small and Family Business will be given to Stuart Robert MP. - The new Minister for Government Services and the NDIS will be Senator Linda Reynolds while the role of Minister for Defence will go to Peter Dutton MP. Minister Dutton will also become Leader of the House. - Karen Andrews MP will be the new Home Affairs Minister and the role of Minister for Industry, Science and Technology will be taken up by Christian Porter MP. - Senator Anne Ruston, the Minister for Families and Social Services will take on the newly created Cabinet role of Minister for Women’s Safety. - Melissa Price MP will maintain her position as Minister for Defence Industry and will return to the Cabinet. Ministry Changes - Two new portfolios have been created: Assistant Minister for Women; and Minister for Women’s Economic Security. - Senator Jane Hume, the Minister for Superannuation, Financial Services and the Digital Economy, will take on the new portfolio of Minister for Women’s Economic Security. - Senator Amanda Stoker, the Assistant Minister to the Attorney-General and the Assistant Minister for Industrial Relations, will add the new role of Assistant Minister for Women to her portfolio responsibilities.
    [Show full text]
  • The Most Promising Therapeutics for COVID-19
    17 May 2020 The Hon Karen Andrews MP Minister for Industry, Science and Technology The Hon Greg Hunt MP Minister for Health Parliament House CANBERRA ACT 2600 CC: Dr Brendan Murphy, Chief Medical Officer Dear Ministers Please find attached a response to your request for an analysis of the available evidence to respond to your question: What are the most promising COVID-19 therapeutics in development globally and nationally, and what are their mechanisms of action, their stage of development and their strengths and limitations? This rapid response has been prepared by the Rapid Research Information Forum that I Chair. The report synthesises the evidence base on this matter and has been informed by relevant experts and has been peer reviewed. Details of the authors and peer reviewers can be found in the Appendix. I hope this document proves useful to you and your colleagues. Yours sincerely, Dr Alan Finkel AO FAA FTSE FAHMS Australia’s Chief Scientist GPO Box 2013 Telephone: +61 2 6102 9210 Email: [email protected] Canberra ACT 2601 Facsimile: +61 2 6213 6558 Web: www.chiefscientist.gov.au Australia Rapid Research Information Forum The most promising therapeutics for COVID-19 17 May 2020 This rapid research brief responds to the question: What are the most promising COVID-19 therapeutics in development globally and nationally, and what are their mechanisms of action, their stage of development and their strengths and limitations? • There are over 200 potential COVID-19 therapeutics being tested in more than 1,100 clinical trials. • As of 17 May 2020, no therapeutic has been shown to be fully effective.
    [Show full text]
  • List of Members 46Th Parliament Volume 6.4 – 03 June 2020
    The Parliament of the Commonwealth of Australia House of Representatives List of Members 46th Parliament Volume 6.4 – 03 June 2020 No. Name Electorate, Party Electorate office details, E-mail address Parliament House State/Territory telephone, fax 1. Albanese, The Hon Anthony Norman Grayndler, ALP E-mail: [email protected] Tel: (02) 6277 4022 Leader of the Opposition NSW 334A Marrickville Road, Fax: (02) 6277 8562 Marrickville NSW 2204 (PO Box 5100, Marrickville NSW 2204) Tel: (02) 9564 3588, Fax: (02) 9564 1734 2. Alexander, Mr John Gilbert OAM Bennelong, LP E-mail: [email protected] Tel: (02) 6277 4804 NSW 32 Beecroft Road, Epping NSW 2121 Fax: (02) 6277 8581 (PO Box 872, Epping NSW 2121) Tel: (02) 9869 4288, Fax: (02) 9869 4833 3. Allen, Dr Katrina Jane (Katie) Higgins, LP E-mail: [email protected] Tel: (02) 6277 4100 VIC 1/1343 Malvern Road, Malvern VIC 3144 Fax: (02) 6277 8408 Tel: (03) 9822 4422, Fax: N/A 4. Aly, Dr Anne Cowan, ALP E-mail: [email protected] Tel: (02) 6277 4876 WA Shop 3, Kingsway Shopping Centre, Fax: (02) 6277 8526 168 Wanneroo Road, Madeley WA 6065 (PO Box 219, Kingsway WA 6065) Tel: (08) 9409 4517, Fax: (08) 9409 9361 5. Andrews, The Hon Karen Lesley McPherson, LNP E-mail: [email protected] Tel: (02) 6277 7070 Minister for Industry, Science and QLD Ground Floor The Point 47 Watts Drive, Technology Varsity Lakes QLD 4227 (PO Box 409, Varsity Lakes QLD 4227) Tel: (07) 5580 9111, Fax: (07) 5580 9700 6.
    [Show full text]